Spotlight on Transitions
This topic of “transition” came home to me (literally and figuratively) over…
The Future of Biopharma Commercialization Strategy Is Now
Back in the early 2000s, I was head of commercial strategy at Millennium…
Biopharma Launch Planning for Emerging Companies: Four Key Challenges
Living in a parallel universe, launching a company and drug simultaneously.
Nature vs. Nurture
We have been publishing these "e-conversations" for just six months now. But I am happy — no, thrilled — to see that it has already become exactly…
Where Has All the Brand Planning Strategy Gone?
Back in the Mesozoic Era, when I was coming up the marketing line (also known as the 90s), we used something called "The Mapping Approach to…
What More Can We Do To Help?
Our last newsletter concluded with the following question: "If you could have an unlimited supply of anything, what would it be?" It was a question…
Important Questions That Move Us Forward
I had two reasons for attending TEDMED in Palm Springs earlier this month. First, I wanted to be inspired! Second, I wanted to learn more about…
Reactive Leadership in Biopharma: Breaking the Whac-A-Mole Cycle
Today we examine a pervasive challenge in our industry: time and resources wasted as middle and senior leaders respond to a seemingly endless, daily…
Your Future Story … How Good Is It?
Summer, sadly, is over. And while there are noticeable shifts with each change of season, I find the transition into autumn can often be bittersweet.